期刊
MEDICAL SCIENCE MONITOR
卷 23, 期 -, 页码 4723-4732出版社
INT SCIENTIFIC LITERATURE, INC
DOI: 10.12659/MSM.902538
关键词
Angiogenesis Inhibitors; Angiotensin II Type 1 Receptor Blockers; Genes; p53; Hydroxyapatites; Inflammatory Breast Neoplasms
Background: Breast cancer is among the deadliest cancers across the world and is responsible for countless deaths. There is an urgent need for co-delivery systems which can simultaneously transport both drug and gene into a single cancer cell with low toxicity and high anti-angiogenesis efficiency. Material/Methods: In the present study, well-formed amine-functionalized hydroxyapatite nanoparticles based on combined angiogenesis therapy for breast cancer were successfully constructed for the simultaneous delivery of p53 and candesartan (CD) (p53/CD/NHAP). Results: In vitro and in vivo experiments revealed that p53/CD/NHAP can effectively transfer the p53 gene and deliver the loaded CD to achieve preferable anti-breast cancer effect both at the cellular level and in tumor-bearing mice. This may possibly be due to the combined anti-angiogenic mechanisms of p53 and CD via different pathways. Conclusions: p53/CD/NHAP might be a candidate carrier for efficient anti-angiogenesis therapy of breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据